Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia

References

• Estey E, Dohner H. Acute myeloid leukaemia. Lancet 2006; 368:1894 - 1907
   PubMed Web of Science ®Google Scholar
• Jabbour EJ, Estey E, Kantarjian HM. Adult acute myeloid leukemia. Mayo Clin Proc 2006; 81:247 - 260
   PubMed Web of Science ®Google Scholar
• Nimer SD. Is it important to decipher the heterogeneity of “normal karyotype AML?”. Best Pract Res Clin Haematol 2008; 21:43 - 52
   PubMed Web of Science ®Google Scholar
• Shimamoto T, Ohyashiki JH, Ohyashiki K. Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia. Leuk Res 2005; 29:653 - 659
   PubMed Web of Science ®Google Scholar
• Aggerholm A, Holm MS, Guldberg P, Olesen LH, Hokland P. Promoter hypermethylation of p15INK4B, HIC1, CDH1 and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients. Eur J Haematol 2006; 76:23 - 32
   PubMed Web of Science ®Google Scholar
• Ekmekci CG, Gutierrez MI, Siraj AK, Ozbek U, Bhatia K. Aberrant methylation of multiple tumor suppressor genes in acute myeloid leukemia. Am J Hematol 2004; 77:233 - 240
   PubMed Web of Science ®Google Scholar
• Plass C, Oakes C, Blum W, Marcucci G. Epigenetics in acute myeloid leukemia. Semin Oncol 2008; 35:378 - 387
   PubMed Web of Science ®Google Scholar
• Baldus CD, Bullinger L. Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia. Semin Oncol 2008; 35:356 - 364
   PubMed Web of Science ®Google Scholar
• Kantarjian H, Issa JP, Rosenfeld CS, Bennett JM, Albitar M, DiPersio J, et al. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer 2006; 106:1794 - 1803
   PubMed Web of Science ®Google Scholar
• Pinto A, Zagonel V. 5-Aza-2′-deoxycytidine (Decitabine) and 5-azacytidine in the treatment of acute myeloid leukemias and myelodysplastic syndromes: past, present and future trends. Leukemia 1993; 7:51 - 60
   PubMed Web of Science ®Google Scholar
• Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A, et al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol 2009; 10:223 - 232
   PubMed Web of Science ®Google Scholar
• Hess CJ, Errami A, Berkhof J, Denkers F, Ossenkoppele GJ, Nygren AO, et al. Concurrent methylation of promoters from tumor associated genes predicts outcome in acute myeloid leukemia. Leuk Lymphoma 2008; 49:1132 - 1141
   PubMed Web of Science ®Google Scholar
• Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD, et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 1990; 8:813 - 819
   PubMed Web of Science ®Google Scholar
• Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93:9821 - 9826
   PubMed Web of Science ®Google Scholar
• Levis M, Murphy KM, Pham R, Kim KT, Stine A, Li L, et al. Internal tandem duplications of the FLT3 gene are present in leukemia stem cells. Blood 2005; 106:673 - 680
   PubMed Web of Science ®Google Scholar
• Corn PG, Kuerbitz SJ, van Noesel MM, Esteller M, Compitello N, Baylin SB, et al. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation. Cancer Res 1999; 59:3352 - 3356
   PubMed Web of Science ®Google Scholar
• Karp JE, Smith BD, Levis MJ, Gore SD, Greer J, Hattenburg C, et al. Sequential flavopiridol, cytosine arabinoside and mitoxantrone: a phase II trial in adults with poor-risk acute myelogenous leukemia. Clin Cancer Res 2007; 13:4467 - 4473
   PubMed Web of Science ®Google Scholar
• Linker CA, Ries CA, Damon LE, Sayre P, Navarro W, Rugo HS, et al. Autologous stem cell transplantation for acute myeloid leukemia in first remission. Biol Blood Marrow Transplant 2000; 6:50 - 57
   PubMed Web of Science ®Google Scholar
• Geller RB, Burke PJ, Karp JE, Humphrey RL, Braine HG, Tucker RW, et al. A two-step timed sequential treatment for acute myelocytic leukemia. Blood 1989; 74:1499 - 1506
   PubMed Web of Science ®Google Scholar
• Bolanos-Meade J, Karp JE, Guo C, Sarkodee-Adoo CB, Rapoport AP, Tidwell ML, et al. Timed sequential therapy of acute myelogenous leukemia in adults: a phase II study of retinoids in combination with the sequential administration of cytosine arabinoside, idarubicin and etoposide. Leuk Res 2003; 27:313 - 321
   PubMed Web of Science ®Google Scholar
• Fenaux P. Myelodysplastic syndromes: From pathogenesis and prognosis to treatment. Semin Hematol 2004; 41:6 - 12
   PubMed Web of Science ®Google Scholar
• Kroeger H, Jelinek J, Estecio MR, He R, Kondo K, Chung W, et al. Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse. Blood 2008; 112:1366 - 1373
   PubMed Web of Science ®Google Scholar
• Jiang Y, Dunbar A, Gondek LP, Mohan S, Rataul M, Saunthararajah Y, et al. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML. Blood 2009; 113:1315 - 1325
   PubMed Web of Science ®Google Scholar
• Tomasini R, Tsuchihara K, Wilhelm M, Fujitani M, Rufini A, Cheung CC, et al. TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev 2008; 22:2677 - 2691
   PubMed Web of Science ®Google Scholar
• Niikura Y, Dixit A, Scott R, Perkins G, Kitagawa K. BUB1 mediation of caspase-independent mitotic death determines cell fate. J Cell Biol 2007; 178:283 - 296
   PubMed Web of Science ®Google Scholar
• Figueroa ME, Reimers M, Thompson RF, Ye K, Li Y, Selzer RR, et al. An integrative genomic and epigenomic approach for the study of transcriptional regulation. PLoS One 2008; 3:1882
   Web of Science ®Google Scholar
• Ongenaert M, Van Neste L, De Meyer T, Menschaert G, Bekaert S, Van Criekinge W. PubMeth: a cancer methylation database combining text-mining and expert annotation. Nucleic Acids Res 2008; 36:842 - 846
   PubMed Web of Science ®Google Scholar
• Shimamoto T, Ohyashiki JH, Ohyashiki K. Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia. Leuk Res 2005; 29:653 - 659
   PubMed Web of Science ®Google Scholar
• Pabst T, Mueller BU, Harakawa N, Schoch C, Haferlach T, Behre G, et al. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8; 21) myeloid leukemia. Nat Med 2001; 7:444 - 451
   PubMed Web of Science ®Google Scholar
• Agrawal S, Hofmann WK, Tidow N, Ehrich M, Van den Boom D, Koschmieder S, et al. The C/EBPdelta tumor suppressor is silenced by hypermethylation in acute myeloid leukemia. Blood 2007; 109:3895 - 3905
   PubMed Web of Science ®Google Scholar
• Liu TX, Becker MW, Jelinek J, Wu WS, Deng M, Mikhalkevich N, et al. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation. Nat Med 2007; 13:78 - 83
   PubMed Web of Science ®Google Scholar
• Iwai M, Kiyoi H, Ozeki K, Kinoshita T, Emi N, Ohno R, et al. Expression and methylation status of the FHIT gene in acute myeloid leukemia and myelodysplastic syndrome. Leukemia 2005; 19:1367 - 1375
   PubMed Web of Science ®Google Scholar
• Zheng S, Ma X, Zhang L, Gunn L, Smith MT, Wiemels JL, et al. Hypermethylation of the 5′ CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia. Cancer Res 2004; 64:2000 - 2006
   PubMed Web of Science ®Google Scholar
• Lenz G, Hutter G, Hiddemann W, Dreyling M. Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemia. Ann Hematol 2004; 83:628 - 633
   PubMed Web of Science ®Google Scholar
• Horton TM, Thompson PA, Berg SL, Adamson PC, Ingle AM, Dolan ME, et al. Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study. J Clin Oncol 2007; 25:4922 - 4928
   PubMed Web of Science ®Google Scholar
• Christiansen DH, Andersen MK, Pedersen-Bjergaard J. Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia. Leukemia 2003; 17:1813 - 1819
   PubMed Web of Science ®Google Scholar
• Wong IH, Ng MH, Huang DP, Lee JC. Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications. Blood 2000; 95:1942 - 1949
   PubMed Web of Science ®Google Scholar
• Chen CY, Tsay W, Tang JL, Shen HL, Lin SW, Huang SY, et al. SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia. Genes Chromosomes Cancer 2003; 37:300 - 305
   PubMed Web of Science ®Google Scholar
• Wu SJ, Yao M, Chou WC, Tang JL, Chen CY, Ko BS, et al. Clinical implications of SOCS1 methylation in myelodysplastic syndrome. Br J Haematol 2006; 135:317 - 323
   PubMed Web of Science ®Google Scholar